EUVIMEDEUVIMED entdecken
Crossref

Pre-clinical study of IR808 dye for cervical cancer in vitro and in vivo imaging

Xiaohui Teng, Hongbiao Chen, Han Yang, Hongli Liu, Yanlong Wang, Zhiying Su, Chu Tang

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03508-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Xiaohui Teng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361000, China. Hauptthemen laut MEDLINE: Fluorescent Dyes, Indoles, Uterine Cervical Neoplasms, Vinyl Compounds. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an urgent need for improved methods for early screening and rapid diagnosis of cervical cancer since current conventional screening methods are plagued by operator subjectivity and unnecessary biopsies. IR808 is a tumour-targeting near-infrared (NIR) fluorescent dye that permits NIR imaging without the requirement of chemical conjugation. Our study investigates an IR808-based strategy for real-time monitoring of the cervix in vivo and rapid assessment of cervical specimens in vitro. We investigated the uptake of IR808 in vitro using normal cervical epithelial cells and three cervical cancer cell lines. The biodistribution of IR808 was examined in vivo via intravenous injection into tumour-bearing mice. Additionally, in vitro tissues were stained with IR808 to simulate the identification of cervical tumors in the clinical setting. Biocompatibility of the dye in both cellular and animal models was also examined. IR808 exhibited significant tumour-to-background ratios in fluorescence molecular imaging of in vivo tumors in nude mice. The application of NIR fluorescent dye IR808 in specific imaging screening, safe and non-invasive real-time monitoring, and rapid identification of cervical tumors from tissue specimens is expected to improve current screening methods for cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorescent DyesIndolesUterine Cervical NeoplasmsVinyl CompoundsAnimalsFemaleHumansMiceBromine CompoundsCell Line, TumorMice, Inbred BALB CMice, NudeOptical ImagingTissue Distribution

Stichwörter der Autor:innen

Cervical cancerDiagnosisFluorescence Molecular ImagingIR808 dye

Substanzen

1-(5-carboxypentyl)-2-(2-(3-(2-(1-(5-carboxypentyl)-3,3-dimethylindolin-2-ylidene)ethylidene)-2-chlorocyclohex-1-en-1-y…2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dime…Bromine CompoundsFluorescent DyesIndolesVinyl Compounds

Autor:innen und Institutionen

  • Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361000, China.
  • School of Medicine, Chenggong Hospital, Xiamen University, Xiamen, 361000, China.
  • Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, 710126, Shaanxi, China. ctang@xidian.edu.cn.

Zitieren

APA

Teng, X., Chen, H., Yang, H., Liu, H., Wang, Y., Su, Z., & Tang, C. (2025). Pre-clinical study of IR808 dye for cervical cancer in vitro and in vivo imaging. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03508-7

Vancouver

Teng X, Chen H, Yang H, Liu H, Wang Y, Su Z, et al. Pre-clinical study of IR808 dye for cervical cancer in vitro and in vivo imaging. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03508-7

BibTeX
@article{Teng2025,
  author = {Teng, Xiaohui and Chen, Hongbiao and Yang, Han and Liu, Hongli and Wang, Yanlong and Su, Zhiying and Tang, Chu},
  title = {Pre-clinical study of IR808 dye for cervical cancer in vitro and in vivo imaging},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03508-7}
}
Kostenlos starten →